References
1. O’Sullivan BP, Freedman SD. Cystic fibrosis. Lancet 2009; 373:
1891-1904.
2. Farrell PM, Kosorok MR, Laxova A, Shen G, Koscik RE, Bruns WT,
Splaingard M, Mischler EH. Nutritional benefits of neonatal screening
for cystic fibrosis. Wisconsin Cystic Fibrosis Neonatal Screening Study
Group. NEnglJ Med 1997; 337: 963-969.
3. Farrell PM, Kosorok MR, Rock MJ, Laxova A, Zeng L, Lai HC, Hoffman G,
Laessig RH, Splaingard ML. Early diagnosis of cystic fibrosis through
neonatal screening prevents severe malnutrition and improves long-term
growth. Wisconsin Cystic Fibrosis Neonatal Screening Study Group.Pediatrics 2001; 107: 1-13.
4. Wagener JS, Zemanick ET, Sontag MK. Newborn screening for cystic
fibrosis. Curr Opin Pediatr 2012; 24: 329-335.
5. Borowitz D, Parad RB, Sharp JK, Sabadosa KA, Robinson KA, Rock MJ,
Farrell PM, Sontag MK, Rosenfeld M, Davis SD, Marshall BC, Accurso FJ.
Cystic Fibrosis Foundation practice guidelines for the management of
infants with cystic fibrosis transmembrane conductance regulator-related
metabolic syndrome during the first two years of life and beyond.J Pediatr 2009; 155: S106-S116.
6. Munck A, Mayell SJ, Winters V, Shawcross A, Derichs N, Parad R,
Barben J, Southern KW. Cystic Fibrosis Screen Positive, Inconclusive
Diagnosis (CFSPID): A new designation and management recommendations for
infants with an inconclusive diagnosis following newborn screening.J Cyst Fibros 2015; 14: 706-713.
7. Ren CL, Borowitz DS, Gonska T, Howenstine MS, Levy H, Massie J, Milla
C, Munck A, Southern KW. Cystic Fibrosis Transmembrane Conductance
Regulator-Related Metabolic Syndrome and Cystic Fibrosis Screen
Positive, Inconclusive Diagnosis. J Pediatr 2017; 181S: S45-S51
e41.
8. Munck A. Inconclusive Diagnosis after Newborn Screening for Cystic
Fibrosis. Int J Neonatal Screen 2020; 6: 19.
9. Gonska T, Keenan K, Au J, Dupuis A, Chilvers MA, Burgess C, Bjornson
C, Fairservice L, Brusky J, Kherani T, Jober A, Kosteniuk L, Price A,
Itterman J, Morgan L, Mateos-Corral D, Hughes D, Donnelly C, Smith MJ,
Iqbal S, Arpin J, Reisman J, Hammel J, van Wylick R, Derynck M,
Henderson N, Solomon M, Ratjen F. Outcomes of Cystic Fibrosis
Screening-Positive Infants With Inconclusive Diagnosis at School Age.Pediatrics 2021; 148.
10. Ren CL, Fink AK, Petren K, Borowitz DS, McColley SA, Sanders DB,
Rosenfeld M, Marshall BC. Outcomes of infants with indeterminate
diagnosis detected by cystic fibrosis newborn screening.Pediatrics 2015; 135: e1386-1392.
11. Knapp EA, Fink AK, Goss CH, Sewall A, Ostrenga J, Dowd C, Elbert A,
Petren KM, Marshall BC. The Cystic Fibrosis Foundation Patient Registry.
Design and Methods of a National Observational Disease Registry.Annals of the American Thoracic Society 2016; 13: 1173-1179.
12. Farrell PM, White TB, Ren CL, Hempstead SE, Accurso F, Derichs N,
Howenstine M, McColley SA, Rock M, Rosenfeld M, Sermet-Gaudelus I,
Southern KW, Marshall BC, Sosnay PR. Diagnosis of Cystic Fibrosis:
Consensus Guidelines from the Cystic Fibrosis Foundation. The
Journal of Pediatrics 2017; 181: S4-S15.e11.
13. Sosnay PR, Siklosi KR, Van Goor F, Kaniecki K, Yu H, Sharma N,
Ramalho AS, Amaral MD, Dorfman R, Zielenski J, Masica DL, Karchin R,
Millen L, Thomas PJ, Patrinos GP, Corey M, Lewis MH, Rommens JM,
Castellani C, Penland CM, Cutting GR. Defining the disease liability of
variants in the cystic fibrosis transmembrane conductance regulator
gene. Nat Genet 2013; 45: 1160-1167.
14. Quanjer PH, Stanojevic S, Cole TJ, Baur X, Hall GL, Culver BH,
Enright PL, Hankinson JL, Ip MS, Zheng J, Stocks J, Initiative ERSGLF.
Multi-ethnic reference values for spirometry for the 3-95-yr age range:
the global lung function 2012 equations. Eur Respir J 2012; 40:
1324-1343.
15. Groves T, Robinson P, Wiley V, Fitzgerald DA. Long-Term Outcomes of
Children with Intermediate Sweat Chloride Values in Infancy. The
Journal of Pediatrics 2015; 166: 1469-1474.e1463.
16. The Clinical and Functional Translation of CFTR (CFTR2); available
at http://cftr2.org.
17. Terlizzi V, Mergni G, Buzzetti R, Centrone C, Zavataro L, Braggion
C. Cystic fibrosis screen positive inconclusive diagnosis (CFSPID):
Experience in Tuscany, Italy. J Cyst Fibros 2019; 18: 484-490.